• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Silexan for treatment of anxiety and depression in the context of COVID-19.西乐葆用于治疗新型冠状病毒肺炎相关的焦虑和抑郁。
Eur Neuropsychopharmacol. 2023 May;70:47-48. doi: 10.1016/j.euroneuro.2023.02.015. Epub 2023 Feb 23.
2
Efficacy of Silexan in mixed anxiety-depression--A randomized, placebo-controlled trial.西乐欣治疗混合性焦虑抑郁障碍的疗效——一项随机、安慰剂对照试验
Eur Neuropsychopharmacol. 2016 Feb;26(2):331-340. doi: 10.1016/j.euroneuro.2015.12.002. Epub 2015 Dec 12.
3
Pharmacological basis of the anxiolytic and antidepressant properties of Silexan®, an essential oil from the flowers of lavender.薰衣草花挥发油思诺思®的抗焦虑和抗抑郁作用的药理学基础。
Neurochem Int. 2021 Feb;143:104899. doi: 10.1016/j.neuint.2020.104899. Epub 2020 Nov 9.
4
An orally administered lavandula oil preparation (Silexan) for anxiety disorder and related conditions: an evidence based review.口服薰衣草油制剂（Silexan）治疗焦虑障碍及相关疾病：基于证据的综述。
Int J Psychiatry Clin Pract. 2013 Nov;17 Suppl 1:15-22. doi: 10.3109/13651501.2013.813555. Epub 2013 Aug 3.
5
Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of 'subsyndromal' anxiety disorder: a randomized, double-blind, placebo controlled trial.Silexan，一种口服薰衣草油制剂，在治疗“亚综合征”焦虑症方面有效：一项随机、双盲、安慰剂对照试验。
Int Clin Psychopharmacol. 2010 Sep;25(5):277-87. doi: 10.1097/YIC.0b013e32833b3242.
6
A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder.一项多中心、双盲、随机研究，比较薰衣草油制剂 Silexan 与劳拉西泮治疗广泛性焦虑症。
Phytomedicine. 2010 Feb;17(2):94-9. doi: 10.1016/j.phymed.2009.10.006. Epub 2009 Dec 3.
7
Lavender Oil Preparation (Silexan) for Treating Anxiety: An Updated Meta-Analysis.用于治疗焦虑症的薰衣草油制剂（西乐葆）：一项更新的荟萃分析。
J Clin Psychopharmacol. 2017 Feb;37(1):115-117. doi: 10.1097/JCP.0000000000000615.
8
Silexan in anxiety disorders: Clinical data and pharmacological background.思乐康治疗焦虑障碍：临床数据和药理学背景。
World J Biol Psychiatry. 2018 Sep;19(6):412-420. doi: 10.1080/15622975.2017.1331046. Epub 2017 Jun 19.
9
Psychiatric manifestations of post-COVID-19 syndrome: the potential benefit of Silexan.新冠病毒感染后综合征的精神表现：西拉西泮的潜在益处。
Int J Psychiatry Clin Pract. 2023 Sep;27(3):285-291. doi: 10.1080/13651501.2023.2187308. Epub 2023 Apr 6.
10
Efficacy of Silexan in subthreshold anxiety: meta-analysis of randomised, placebo-controlled trials.西拉香兰素治疗阈下焦虑的疗效：随机、安慰剂对照试验的荟萃分析。
Eur Arch Psychiatry Clin Neurosci. 2019 Mar;269(2):183-193. doi: 10.1007/s00406-017-0852-4. Epub 2017 Nov 17.

引用本文的文献

1
Silexan in anxiety, depression, and related disorders: pharmacological background and clinical data.西来赞用于焦虑、抑郁及相关障碍：药理学背景与临床数据。
Eur Arch Psychiatry Clin Neurosci. 2024 Oct 25. doi: 10.1007/s00406-024-01923-8.
2
Multi-target drugs for the treatment of cognitive impairment and fatigue in post-COVID syndrome: focus on Ginkgo biloba and Rhodiola rosea.用于治疗新冠后综合征认知障碍和疲劳的多靶标药物：以银杏叶和红景天为例。
J Neural Transm (Vienna). 2024 Mar;131(3):203-212. doi: 10.1007/s00702-024-02749-3. Epub 2024 Feb 12.

Silexan for treatment of anxiety and depression in the context of COVID-19.

作者信息

Bartova Lucie, Dold Markus, Fugger Gernot, Weidenauer Ana, Rujescu Dan, Kasper Siegfried

机构信息

Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria.

Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria; Psychiatric Day Hospital, University Hospital St. Poelten, St. Poelten, Austria; Karl Landsteiner Private University of Health Sciences, Krems an der Donau, Austria.

出版信息

Eur Neuropsychopharmacol. 2023 May;70:47-48. doi: 10.1016/j.euroneuro.2023.02.015. Epub 2023 Feb 23.

DOI:10.1016/j.euroneuro.2023.02.015
PMID:36867894
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9946880/
Abstract
摘要